APOE and hypertensive disorder: Even after adjusting for age, sex, the prevalence of traditional CV risk factors (T2DM, hypertension, and smoking), and statin usage, there was no association between APOE polymorphisms and primary endpoint incidence (OR 0.9, 95%CI 0.3-3.1, p=0.89 and 1.3, 95%CI 0.5-3.3, p=0.62 for APOE2 and APOE4 carriers, respectively, when compared with APOE3 homozygotes).